To elucidate the mechanism by which Pembrolizumab affected the radiosensitivity of tumor cells (NCI-H460 and ZR-75-30), we conducted qRT-PCR to check the expression of miR-20b-5p and WB to monitor the expression of the PD-L1/PD1 pathway. This evidence concerns the gene CD274 and neoplasm.